Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.

Ruiz-Limón, Patricia; Ortega, Rafaela; Arias de la Rosa, Ivan; Abalos-Aguilera, Maria Del Carmen; Perez-Sanchez, Carlos; Jimenez-Gomez, Yolanda; Peralbo-Santaella, Esther; Font, Pilar; Ruiz-Vilches, Desiree; Ferrin, Gustavo; Collantes-Estevez, Eduardo; Escudero-Contreras, Alejandro; López-Pedrera, Chary; Barbarroja, Nuria.
Transl Res; 183: 87-103, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-28027930